Subcutaneous implantable cardioverter defibrillator for dialysis patients: A strategy to reduce central vein stenoses and infections

American Journal of Kidney Diseases

Volumn 66, Issue 1, 2015, Pages 154-158

  Dhamija, Rajiv K ^a   Tan, Henry ^b   Philbin, Edward ^b   Mathew, Roy O ^b,c   Sidhu, Mandeep S ^b,c   Wang, Jeffrey ^c   Saour, Basil ^b   Haqqie, Syed S ^b   Beathard, Gerald ^d   Yevzlin, Alexander S ^e   Salman, Loay ^f   Boden, William E ^b,c   Siskin, Gary ^b   Asif, Arif ^b  

^a RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

arteriovenous fistula (AVF); cardiac leads; central venous stenosis; end stage renal disease (ESRD); hemodialysis; infection; Subcutaneous implantable cardioverter defibrillator (SICD); tunneled dialysis catheter; venous occlusion

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTERIOVENOUS FISTULA; ARTICLE; CASE REPORT; CENTRAL VEIN; CENTRAL VEIN INFECTION; CENTRAL VEIN STENOSIS; DEVICE REMOVAL; DIALYSIS CATHETER; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEMATOMA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG QT SYNDROME; MALE; MIDDLE AGED; MINIMALLY INVASIVE PROCEDURE; NONISCHEMIC CARDIOMYOPATHY; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; RECURRENT DISEASE; RESUSCITATION; SECONDARY PREVENTION; SUDDEN CARDIAC DEATH; THROMBOSIS; VASCULAR STENT; VEIN DISEASE; VEIN OCCLUSION; ADVERSE EFFECTS; ARTERIOVENOUS SHUNT; BRACHIOCEPHALIC VEIN; CARDIOVERSION; CATHETERIZATION; CENTRAL VENOUS CATHETER; COMPLICATION; CONSTRICTION, PATHOLOGIC; DEATH, SUDDEN, CARDIAC; ELECTRODE IMPLANT; FOLLOW UP; KIDNEY FAILURE, CHRONIC; PATHOLOGY; RENAL REPLACEMENT THERAPY; STENT; SUBCUTANEOUS TISSUE; THROMBECTOMY;

ADULT; AGED; ANGIOPLASTY; ARTERIOVENOUS SHUNT, SURGICAL; BRACHIOCEPHALIC VEINS; CATHETERIZATION; CONSTRICTION, PATHOLOGIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; LONG QT SYNDROME; MALE; MIDDLE AGED; RENAL DIALYSIS; STENTS; SUBCUTANEOUS TISSUE; THROMBECTOMY; THROMBOSIS; VASCULAR ACCESS DEVICES;

EID: 84937513904     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.01.028     Document Type: Article

References (28)

1. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, and et al. ACC,AHA,HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities Circulation 117 2008 e350 e408
2. A.J. Moss, W. Zareba, W.J. Hall, and et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
3. G.H. Bardy, K.L. Lee, D.B. Mark Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. A.S. Desai, J.C. Fang, W.H. Maisel, and K.L. Baughman Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879
5. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
6. D.A. Drew, K.B. Meyer, and D.E. Weiner Transvenous cardiac device wires and vascular access in hemodialysis patients Am J Kidney Dis 58 2011 494 496
7. A. Asif, R. Carrillo, J.D. Garisto, and et al. Epicardial cardiac rhythm devices for dialysis patients: minimizing the risk of infection and preserving central veins Semin Dial 25 2012 88 94
8. A. Asif, L. Salman, G. Lopera, S.S. Haqqie, and R. Carrillo Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination Semin Dial 25 2012 582 586
9. G. Lin, R.A. Nishimura, H.M. Connolly, and et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter defibrillator leads J Am Coll Cardiol 45 2005 1672 1675
10. D.J. Heaven, M.Y. Henein, and R. Sutton Pacemaker lead related tricuspid stenosis. A report of two cases Heart 83 2000 351 352
11. H. Ribeiro, P. Magalhães, C. Ferreira, and et al. Pacemaker lead-induced tricuspid stenosis: a report of two cases Rev Port Cardiol 31 2012 305 308
12. R.G. Carrillo, J.D. Garisto, L. Salman, D. Merrill, and A. Asif Contamination of transvenous pacemaker leads due to tunneled hemodialysis catheter infection: a report of 2 cases Am J Kidney Dis 55 2010 1097 1101
13. R.G. Carrillo, J.D. Garisto, L. Salman, and A. Asif Arteriovenous dialysis access-associated transvenous pacemaker infection Clin Nephrol 75 2011 174 178
14. T.F. Saad, D. Hentschel, B. Koplan, and et al. Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice Semin Dial 26 2013 114 123
15. L.M. Baddour, A.E. Epstein, and C.C. Erickson Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation 121 2010 458 477
16. C.H. Cabell, P.A. Heidenreich, V.H. Chu, and et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999 Am Heart J 147 2004 582 586
17. J.C. Lekkerkerker, C. van Nieuwkoop, S.A. Trines, and et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry Heart 95 2009 715 720
18. A. Voigt, A. Shalaby, and S. Saba Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003 J Am Coll Cardiol 48 2006 590 591
19. A.L. Chamis, G.E. Peterson, C.H. Cabell, and et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators Circulation 104 2001 1029 1033
20. S.S. Da Costa, A. Scalabrini Neto, R. Costa, and et al. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study Pacing Clin Electrophysiol 25 2002 1301 1306
21. C. Sticherling, S.P. Chough, R.L. Baker, and et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads Am Heart J 141 2001 813 816
22. A. Asif, L. Salman, R.G. Carrillo, and et al. Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study Semin Dial 22 2009 671 676
23. T.H. Teruya, A.M. Abou-Zamzam Jr., W. Limm, and L. Wong Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers Ann Vasc Surg 17 2003 526 529
24. B.L. Wilkoff, C.J. Love, C.L. Byrd, and et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA) Heart Rhythm 6 2009 1085 1104
25. M.R. Sohail, D.Z. Uslan, A.H. Khan, and et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections J Am Coll Cardiol 49 2007 1851 1859
26. H. Bloom, B. Heeke, A. Leon, and et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery Pacing Clin Electrophysiol 29 2006 142 145
27. A.J. Greenspon, E.S. Rhim, G. Mark, and et al. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Pacing Clin Electrophysiol 31 2008 548 553
28. D.M. Charytan, A.R. Patrick, J. Liu, and et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States Am J Kidney Dis 58 2011 409 417